Yearly STL Archives: 2023
Protected: Review of Dermato-Surgery Peri-Procedure Care Promoting Wound Healing
Charles W Lynde MD, FRCPC1, Joel Claveau MD, FRCPC, DABD2, Lyn Guenther MD FRCP3, Sameh Hanna MD, FRCP, DABD4, Angela Law MD, FRCPC5, Monica...
Antibiotic Resistance in Dermatology Part 2: Combating Resistance
The proper and suitable application of antibiotics is crucial in maintaining their effectiveness amidst growing antibiotic resistance. Nevertheless, it is essential for prescribing practitioners to have a heightened understanding of resistance causes and strategies to counteract them.
Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada
Chlormethine gel, a topical antineoplastic agent, has shown safety and efficacy in phase II trials and real-world data for treating adult Mycosis Fungoides patients. Despite potential skin-related side effects, chlormethine gel offers a convenient, skin-directed treatment for stage IA and IB MF-CTCL, addressing an unmet need in Canada.
Update on Drugs & Devices: March – April 2023
Update on Abrocitinib tablet (Cibinqo®), Lanadelumab-flyo SC injection (Takhzyro®), Berdazimer gel, 10.3% (SB206), Methotrexate oral solution, 2 mg/mL (Jylamvo®), and Anticancer plasmid DNA vaccine (ITI-3000).
Understanding Psoriasis: Insights from Les Journées Dermatologiques de Paris
Drs. Joël Claveau & Julien Ringuet, two Canadian dermatologists with prominent clinical and research practices, attended the Les Journées Dermatologiques de Paris conference in Nov-Dec 2022, with a focus on presentations and posters about psoriasis. This article reviews key insights they obtained at the meeting.
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults
Tralokinumab is an effective and safe treatment for adult patients with moderate-to-severe AD. It may be used alone or in combination with TCS. This biologic can be considered first-line treatment after failure of or intolerance to topical therapies.
Antibiotic Resistance in Dermatology Part 1: Mechanisms of Resistance
Awareness of the molecular mechanisms of antibiotic resistance among bacteria is necessary to understand the etiology of antibiotic resistance in dermatology at the most basic level.
Update on Drugs & Devices: January – February 2023
Update covering: Deucravacitinib tablets (Sotyktu™), mRNA vaccine + pembrolizumab IV combination therapy (mRNA-4157/V940 + Keytruda®), Adalimumab-aacf SC injection (Idacio®), Dupilumab for SC injection (Dupixent®), and Spesolimab IV injection (Spevigo®).